* Preliminary U.S. net sales of eylea injection of $858
million for Q4 2016
The post BRIEF-Regeneron Pharmaceuticals reports preliminary Q4 U.S. net sales of eylea injection of $858 mln appeared first on NASDAQ.
BRIEF-Regeneron Pharmaceuticals reports preliminary Q4 U.S. net sales of eylea injection of $858 mln
